The stability of this product in solution has not been determined. Various sources suggest that stock solutions may be stored in aliquots at ?20°C for 1 month and at ?80°C for 6 months. This information has not been validated.
Fortfahren mit
A265
ARL 67156 trisodium salt hydrate
≥98% (HPLC), solid, ecto-ATPase inhibitor
Synonym(e):
6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate trisodium salt hydrate, FPL 67156
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
5 mg | Warenkorb auf Verfügbarkeit prüfen | € 285,00 |
25 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.070,00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C15H21Br2N5Na3O12P3 · xH2O
CAS-Nummer:
Molekulargewicht:
785.05 (anhydrous basis)
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
solid
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenProduktname
ARL 67156 trisodium salt hydrate, ≥98% (HPLC), solid
Quality Segment
assay
≥98% (HPLC)
form
solid
color
white to off-white
solubility
H2O: >20 mg/mL, DMSO: insoluble
storage temp.
−20°C
SMILES string
O.[Na+].[Na+].[Na+].CCN(CC)c1ncnc2n(cnc12)[C@@H]3O[C@H](COP(O)(=O)OP([O-])(=O)C(Br)(Br)P([O-])([O-])=O)[C@@H](O)[C@H]3O
InChI
1S/C15H24Br2N5O12P3.3Na.H2O/c1-3-21(4-2)12-9-13(19-6-18-12)22(7-20-9)14-11(24)10(23)8(33-14)5-32-37(30,31)34-36(28,29)15(16,17)35(25,26)27;;;;/h6-8,10-11,14,23-24H,3-5H2,1-2H3,(H,28,29)(H,30,31)(H2,25,26,27);;;;1H2/q;3*+1;/p-3/t8-,10-,11-,14-;;;;/m1..../s1
InChI key
UWMONIJVKGTUGE-OPKBHZIBSA-K
Gene Information
human ... ENTPD2(954)
General description
ARL 67156, a nucleotide/ATP analog is a competitive inhibitor of CD39. This ecto-ATPase inhibitor is presumed to be metabolically stable in biological studies due to its β, γ-dibromomethylene bridge.
ARL-67156 preferentially inhibits the degradation of ADP compared to the degradation of ATP in the murine colon. It is commonly employed to inhibit ATP hydrolysis in tissue preparations.
Application
Biochem/physiol Actions
ecto-ATPase inhibitor; prevents metabolism of P2 purinoceptor agonists.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description ≥98% (HPLC), solid | description ≥98% (HPLC), solid | description ≥98% (HPLC), solid | description ≥98% (HPLC) |
| form solid | form solid | form solid | form - |
| assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| storage temp. −20°C | storage temp. −20°C | storage temp. - | storage temp. −20°C |
| solubility H2O: >20 mg/mL, DMSO: insoluble | solubility H2O: soluble | solubility H2O: soluble | solubility H2O: >10 mg/mL, DMSO: 1.1 mg/mL |
| color white to off-white | color white | color off-white to light tan | color - |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
-
What is the stability of Product A265, ARL 67156 trisodium salt hydrate, in solution (water)?
1 answer-
Helpful?
-